Epidemiological Situation and Medical Management of Gynaecological and Breast Cancers from 1998 to 2018 in West Africa: A Systematic Review

Authors

  • Abdou Azaque Zoure 1 Department of Biomedical and Public Health, Research Institute of Health Sciences (IRSS / CNRST), 03 BP 7192 Ouagadougou 03, Burkina Faso. 2 Laboratory of Molecular Biology and Genetics (LABIOGENE), Joseph KI-ZERBO University, 03 BP 7021, Ouagadougou 03, Burkina Faso.
  • Bagora Bayala Laboratory of Molecular Biology and Genetics (LABIOGENE), Joseph KI-ZERBO University, 03 BP 7021, Ouagadougou 03, Burkina Faso. Pietro Annigoni Biomolecular Research Center (CERBA), 01 BP 216 Ouagadougou 01, Burkina Faso. Norbert ZONGO University, BP 376 Koudougou, Burkina Faso
  • Hierrhum Aboubacar Bambara Service oncology and clinical haematology, University Hospital BOGODOGO, 01 BP: 5069 Ouagadougou 01, University Joseph KI ZERBO, UFR/SDS, Ouagadougou, Burkina Faso.
  • Alexis Yobi Sawadogo Service of Gynaecology, University Hospital BOGODOGO, University Joseph KI ZERBO, UFR/SDS, Ouagadougou, Burkina Faso.
  • Charlemagne Ouedraogo Service of Gynaecology, University Hospital BOGODOGO, University Joseph KI ZERBO, UFR/SDS, Ouagadougou, Burkina Faso.
  • Jean-Marc A. Lobaccaro Genetic, Reproduction & Development Laboratory, UMR CNRS 6293, INSERM U1103, France.
  • Jacques Simpore Laboratory of Molecular Biology and Genetics (LABIOGENE), Joseph KI-ZERBO University, 03 BP 7021, Ouagadougou 03, Burkina Faso. Pietro Annigoni Biomolecular Research Center (CERBA), 01 BP 216 Ouagadougou 01, Burkina Faso

Keywords:

Gynaecological, Cancers, Management, West Africa

Abstract

Objective: Gynaecological cancers are public health diseases and contribute to the global burden of diseases. In West Africa most have been carried out on all gynaecological and breast cases to describe the epidemiological features and management modalities.
Methods: Our research covered a period from 1998 to 2018. The terms “gynaecological cancers” and “West Africa”; are used to find records in the research databases (PubMed, ScienceDirect, Scopus and Google Scholar). There are countries (Cape Verde, Guinea, Gambia, Liberia, Sierra Leone) in which we have not found any work in the research databases. The process for selecting studies followed selection steps based on PRISMA 2009.
Result: Cervical cancer is the commonest, followed by breast cancer, ovarian cancer, uterine or endometrial cancers, vaginal cancer and vulvar cancer. The lowest common was tubal cancers. The two English-speaking countries, Nigeria and Ghana, recorded 60 (60.82%) and 16 (15.68%) articles published respectively. At the same time, these two countries reported the most cases of gynaecological cancers including 72,848 cases (68.97%), 12, 327 cases (11.67%) and 12, 021 cases (11.38%) for Nigeria, Cote d’Ivoire and Ghana respectively. West Africa countries are characterised by poor outcome due to ignorance, superstition, self-denial, late presentation and unavailability of treatment facilities.
Conclusion: Our study suggests that comprehensive national health insurance schemes as well as preventive strategies, patient and health work force education may improve the current situation. Also, West African countries must necessarily have a policy of acquiring the technical platforms to carry out these diagnostic and prognostic examinations.

Downloads

Published

2020-12-07

Issue

Vol. 5 No. 4 (2020)

Section

Systematic Review and Meta-analysis:

License

 West Asia Organization for Cabcer Prevention retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4 (This permits anyone to copy, distribute, transmit and adapt the published work, provided the original work and source are appropriately cited).